Adverse Drug Reactions

Armstrong, B. , Dinan, B. & Jick, H. (1976). Fatal drug reactions in patients admitted to surgical services, Am. J. Surgery, 132, 643-645.

Bakke, O.M. , Wardell, W.M. & Lasagna, L. (1984). Drug discontinuations in the UK and the USA 1964-1983: Issues of Safety. Clin. Pharamacol. & Therap., 35, 559-567.

Colin-Jones, D. , Langman, M.J.S. , Lawson, D.H. & Vessey, M.P. (1983). Postmarketing surveillance of the safety of Cimetidine: 12 month mortality report. Br. med. J., 286, 1712-1716.

Crombie, I. (1984). Inherent limitations of the Yellow Card System for the detection of unsuspected adverse drug reactions. Human Toxicol., 3, 261-269.

Dollery, C.T. & Rawlins, M.D. (1977). Monitoring adverse reactions to drugs. Br. Med. J., 1, 96-97.

Editorial. (1982a). Benoxaprofen. Br. med. J., 285, 459-460.

Editorial. (1982b). Lesson from the benoxaprofen affair. Lancet, ii, 529-530.

Editorial. (1984). Pharmacoepidemiology: a new discipline. Br. med. J., 289, 940-941.

Griffin, J. (1984). An international survey of adverse drug reactions and reporting. Br. J. Clin. Pharmacol. (supplement - in press).

Harcus, A.W. , Ward, A.E. & Smith, D.W. (1979). Methodology of monitored release of a new preparation: buprenorphine. Br. med. J., 11, 163-165.

Inman, W.H.W. (1980). Postmarketing surveillance in the general population: The UK. In Monitoring for Drug Safety, ed. W. H. W. Inman , pp. 9-47. Lancaster, England: MTP Press.

Inman, W.H.W. (1981). Postmarketing surveillance of adverse drug reactions in general practice. Br. med. J. 282, 1131-1131 & 1216-1217.

Jick, H. (1974). Drugs - remarkably non-toxic. New Engl. J. Med., 291, 824-828.

Lawson, D.H. (1984). Postmarketing surveillance in UK - 1984. Br. J. Clin. Pharmacol., (supplement - in press).

Maclay, W.P. , Crowder, D. , Spiro, S. & Turner, P. (1984). Postmarketing surveillance: practical experience with ketotifen. Br. med. J., 288, 911-914.

Mitchell, J.R.A. (1984). Who needs clinical pharmacology? Br. Med. J., 289, 1119-1120.

Porter, J. & Jick, H. (1977). Drug-related deaths among medical inpatients. J. Amer. med. Ass., 237, 879-881.

Rawlins, M.D. (1981). Adverse reactions to drugs. Br. med. J., 282, 974-976.

Spiers, C.J. , Griffin, J.P. , Weber, J.C.P. , Glen-Bott, M. & Twomey, C. (1984). Demography of the UK adverse reactions register of spontaneous reports. Health Trends, 16, 49-52.

Turner, P. (1984). Food and Drugs: Why different approaches to their safety? Lancet, i, 1116-1117.

Venning, G.R. (1983). Identification of adverse reactions to new drugs . Br. med. J, 286, 199-202; 289-292; 365-368; 458-460; 544-547.

Wardell, W.M. (1974). Therapeutic implications of the drug lag. Clin. Pharmacol. & Therapeut., 15, 73-96.